Mistaken approval of Alzheimer’s Drug
Second Opinion
English - June 13, 2021 13:35 - 5 minutes - 3.67 MB - ★★★★★ - 62 ratingsArts Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Marketing low value products
Next Episode: Estimating the chance of disease
Aducanumab is not just a drug that doesn’t seem to work, but it is an enormously expensive drug but provides false hope to desperate families.